...
首页> 外文期刊>Journal of Medical Case Reports >Cardiac resynchronization therapy improves heart failure in one patient with acromegaly-induced cardiomyopathy: a case report
【24h】

Cardiac resynchronization therapy improves heart failure in one patient with acromegaly-induced cardiomyopathy: a case report

机译:心脏再同步治疗可改善一名肢端肥大性心肌病患者的心力衰竭:一例报告

获取原文
           

摘要

Abstract BackgroundCongestive heart failure is rarely observed in patients with acromegaly. Excessive growth hormone secretion and elevation of insulin-like growth factor 1 contribute to pathological changes in myocyte growth and structure, cardiac contractility, vascular function, and in later stage may progress to cardiac dysfunction. Early recognition of the condition is paramount, though the insidious progression of the disease commonly results in late diagnosis. Current standard regimens of pharmacological therapy, surgical treatment, radiotherapy are designed to normalize serum levels of both insulin-like growth factor 1 and growth hormone. In patients with late-stage heart failure due to acromegalic cardiomyopathy, cardiac resynchronization therapy might be a desirable treatment to help cardiac synchronization, improve symptoms, and eventually reduce hospital admissions together with mortality rates.Case presentationWe describe a case of a 49-year-old man with a history of acromegaly who presented to our hospital with a diagnosis of decompensated systolic heart failure. Serial electrocardiograms showed wide (160–200?ms) QRS duration with left bundle branch block. Echocardiography showed severe left ventricular dysfunction that simultaneously achieved a left ventricular ejection fraction of 16%. Surgical indication was rarely assessed by neurosurgeons. Given that the stereotactic radiosurgery together with pharmacotherapy produced infinitesimal effects, cardiac resynchronization therapy was performed. Owing to biventricular synchronization and holding back reverse remodeling, the patient’s symptoms were successfully alleviated, and he was discharged from the hospital.ConclusionsCongestive heart failure is a rare complication in acromegaly-induced cardiomyopathy (occurs in only 3% of patients). Early diagnosis and treatment with curative drugs more than cardiovascular implantable electronic devices might lead to better surgical outcomes in this group of patients.
机译:摘要背景肢端肥大症患者很少观察到充血性心力衰竭。过多的生长激素分泌和胰岛素样生长因子1升高会导致心肌细胞生长和结构,心脏收缩力,血管功能的病理变化,并在后期可能发展为心脏功能障碍。尽管疾病的隐匿性进展通常会导致晚期诊断,但尽早识别该病至关重要。当前药物治疗,外科治疗,放射治疗的标准方案旨在使胰岛素样生长因子1和生长激素的血清水平正常化。在患有肢端肥大性心肌病的晚期心力衰竭患者中,心脏再同步治疗可能是一种理想的治疗方法,可帮助心脏同步,改善症状并最终降低住院率和死亡率。患有肢端肥大症的老人到我院诊断为代偿性收缩期心力衰竭。连续心电图检查显示QRS持续时间宽(160-200?ms),左束支传导阻滞。超声心动图显示严重的左心功能不全,同时左心室射血分数达到16%。神经外科医生很少评估手术适应症。鉴于立体定向放射外科手术与药物治疗共同产生了微乎其微的效果,因此进行了心脏再同步治疗。由于双心室同步和阻止反向重塑,患者的症状得以成功缓解,并已出院。结论充血性心力衰竭是肢端肥大症引起的心肌病的罕见并发症(仅3%的患者)。与这类可植入式电子设备相比,使用治愈性药物进行早期诊断和治疗可能会导致这类患者获得更好的手术效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号